Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Heterozygous apolipoprotein (a) status and protein expression as a risk factor for premature coronary heart disease.

Martín S, Pedro-Botet J, Joven J, Simó JM, Ladona MG, Pavesi M, Rubiés-Prat J.

J Lab Clin Med. 2002 Mar;139(3):181-7.

PMID:
11944029
2.
3.

SHV-1 beta-lactamase is mainly a chromosomally encoded species-specific enzyme in Klebsiella pneumoniae.

Chaves J, Ladona MG, Segura C, Coira A, Reig R, Ampurdanés C.

Antimicrob Agents Chemother. 2001 Oct;45(10):2856-61.

5.

Pharmacogenetic profile of xenobiotic enzyme metabolism in survivors of the Spanish toxic oil syndrome.

Ladona MG, Izquierdo-Martinez M, Posada de la Paz MP, de la Torre R, Ampurdanés C, Segura J, Sanz EJ.

Environ Health Perspect. 2001 Apr;109(4):369-75.

6.

Cocaine metabolism in human fetal and adult liver microsomes is related to cytochrome P450 3A expression.

Ladona MG, Gonzalez ML, Rane A, Peter RM, de la Torre R.

Life Sci. 2000 Dec 15;68(4):431-43.

PMID:
11205892
7.

Biotransformation and clearance of 3-(phenylamino)propane-1,2-diol, a compound present in samples related to toxic oil syndrome, in C57BL/6 and A/J mice.

Ladona MG, Bujons J, Messeguer A, Ampurdanés C, Morató A, Corbella J.

Chem Res Toxicol. 1999 Dec;12(12):1127-37.

PMID:
10604860
8.

Differential expression of double-band apolipoprotein(a) phenotypes in healthy Spanish subjects detected by SDS-agarose immunoblotting.

Martín S, Ladona MG, Pedro-Botet J, Covas MI, Rubiés-Prat J.

Clin Chim Acta. 1998 Oct;277(2):191-205.

PMID:
9853702
9.

CYP2D6 genotypes in Spanish women with breast cancer.

Ladona MG, Abildúa RE, Ladero JM, Román JM, Plaza MA, Agúndez JA, Muñoz JJ, Benítez J.

Cancer Lett. 1996 Jan 19;99(1):23-8.

PMID:
8564925
10.

Genetic basis for differences in debrisoquin polymorphism between a Spanish and other white populations.

Agúndez JA, Martínez C, Ledesma MC, Ladona MG, Ladero JM, Benítez J.

Clin Pharmacol Ther. 1994 Apr;55(4):412-7.

PMID:
7909282
11.
12.

Differential foetal development of the O- and N-demethylation of codeine and dextromethorphan in man.

Ladona MG, Lindström B, Thyr C, Dun-Ren P, Rane A.

Br J Clin Pharmacol. 1991 Sep;32(3):295-302.

13.

Polymorphic formation of morphine from codeine in poor and extensive metabolizers of dextromethorphan: relationship to the presence of immunoidentified cytochrome P-450IID1.

Mortimer O, Persson K, Ladona MG, Spalding D, Zanger UM, Meyer UA, Rane A.

Clin Pharmacol Ther. 1990 Jan;47(1):27-35.

PMID:
2295216
14.
15.

Monoclonal antibody directed detection of cytochrome P-450 (PCN) in human fetal liver.

Ladona MG, Park SS, Gelboin HV, Hammar L, Rane A.

Biochem Pharmacol. 1988 Dec 15;37(24):4735-41.

PMID:
3264502
16.

Dihydropyridine modulation of the chromaffin cell secretory response.

Ladona MG, Aunis D, Gandía L, García AG.

J Neurochem. 1987 Feb;48(2):483-90.

PMID:
2432183
17.

Influence of hypertonic solutions on catecholamine release from intact and permeabilized cultured chromaffin cells.

Ladona MG, Bader MF, Aunis D.

Biochim Biophys Acta. 1987 Jan 19;927(1):18-25.

PMID:
3790619
18.

Effects of hypertonic solutions on catecholamine release from cat adrenal glands.

Ladona MG, Sanchez-García P, García AG.

Neuroscience. 1984 May;12(1):301-7.

PMID:
6462450

Supplemental Content

Loading ...
Support Center